Literature DB >> 30044940

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

Qian Shi1, James Paul2, Axel Grothey1,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30044940     DOI： 10.1056/NEJMc1805498

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer.

Authors:  Siyuan Weng; Zaoqu Liu; Xiaofeng Ren; Hui Xu; Xiaoyong Ge; Yuqing Ren; Yuyuan Zhang; Qin Dang; Long Liu; Chunguang Guo; Richard Beatson; Jinhai Deng; Xinwei Han
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

2.  Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis.

Authors:  Quan Zhao; Yaxin Long; Wen Cheng; Yingguang Huang; Jinyuan Li; Yuejin Li; Xing Li; Xiaodong Guo; Yu Li; Guosan Li; Kunmei Gong; Jian Zhang
Journal:  Int J Oncol       Date:  2022-05-04       Impact factor: 5.884

3.  Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.

Authors:  Alexandros Lalos; Ali Tülek; Nadia Tosti; Robert Mechera; Alexander Wilhelm; Savas Soysal; Silvio Daester; Venkatesh Kancherla; Benjamin Weixler; Giulio C Spagnoli; Serenella Eppenberger-Castori; Luigi Terracciano; Salvatore Piscuoglio; Markus von Flüe; Alberto Posabella; Raoul A Droeser
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer.

Authors:  Wen Luo; Qingan Liu; Xinwen Chen; Haijun Liu; Bin Quan; Jinli Lu; Ke Zhang; Xiangling Wang
Journal:  Biomed Res Int       Date:  2021-06-09       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.